Cretin E: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) (Created page with "{{person}}") |
Beno Marija (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{ | {{Person | ||
|lastname=Cretin | |||
|firstname=Emma | |||
|institution=Institut Necker Enfants Malades | |||
|address=14 rue MH Vieira Da Silva | |||
|area code=CS 61431 - 75993 | |||
|city=Paris - Cedex 14 | |||
|mailaddress=emma.cretin@inserm.fr | |||
}} | |||
{{Labelingperson}} | |||
Revision as of 15:40, 2 June 2017
| Name | Cretin Emma, |
|---|---|
| Institution | Institut Necker Enfants Malades |
| Address | 14 rue MH Vieira Da Silva, CS 61431 - 75993 |
| City | Paris - Cedex 14 |
| State/Province | |
| Country | |
| emma.cretin@inserm.fr | |
| Weblink | |
| O2k-Network Lab |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Cretin 2021 EMBO Mol Med | 2021 | Cretin E, Lopes P, Vimont E, Tatsuta T, Langer T, Gazi A, Sachse M, Yu-Wai-Man P, Reynier P, Wai T (2021) High-throughput screening identifies suppressors of mitochondrial fragmentation in OPA1 fibroblasts. EMBO Mol Med 13:13579. |
